Nanotechnology in Urolithiasis: Transformative Approaches for Kidney Stone Theranostics

被引:0
|
作者
Prachi, Manpreet
Kaur, Manpreet [1 ]
Varanasi, Roja [2 ]
Nayak, Debadatta [2 ]
Tandon, Chanderdeep [3 ]
Agrawal, Vishal [1 ]
Tandon, Simran [4 ]
机构
[1] Amity Univ Punjab, Mohali 140308, India
[2] Cent Council Res Homeopathy, New Delhi 110058, India
[3] Amity Univ Uttar Pradesh, Noida 201301, India
[4] Amity Univ Uttar Pradesh, Amity Inst Mol Med & Stem Cell Res, Noida 201301, India
关键词
Urolithiasis; Nanoparticles; Theranostics; Kidney stones; Nanotechnology; SILVER NANOPARTICLES; OXIDE NANOPARTICLES; IN-VITRO; EXTRACT; MANAGEMENT; DISEASE; RISK;
D O I
10.1007/s12668-024-01760-y
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Nephrolithiasis often known as urolithiasis or kidney stone disease, is a painful and recurring condition that affects millions of people worldwide. It is a major public health concern owing to its rising prevalence, which is influenced by factors such as geography, diet, lifestyle, and gender. Traditional therapeutic approaches do exist; however, they are not completely efficient in preventing recurrence. Nanotechnology introduces a paradigm shift in kidney stone management by enabling the use of nanoparticles (NPs) for kidney stone management through improved therapy and diagnostic tools. This review delves into the various metal, carbon, silica, selenium, and polymer-based NPs for their application in the field of urolithiasis. However, continued research is needed to implement and improve nanoparticle-based therapies and imaging techniques which can overcome the current limitations, and ensure safe and efficient applications in the field of urolithiasis.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Urolithiasis: the influence of stone size on management
    Ali Mahmood
    Allen Silbergleit
    Ronald Olson
    Michael Cotant
    Nature Clinical Practice Urology, 2007, 4 : 570 - 573
  • [32] Kidney Cancer, urolithiasis
    Ouzaid, I.
    PROGRES EN UROLOGIE, 2017, 27 (01): : F21 - F22
  • [33] Kidney cancer, urolithiasis
    Ouzaid, I.
    PROGRES EN UROLOGIE, 2012, 22 (02): : F74 - F75
  • [34] Urolithiasis: the influence of stone size on management
    Mahmood, Ali
    Silbergleit, Allen
    Olson, Ronald
    Cotant, Michael
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (10): : 570 - 573
  • [35] Hypertension and urolithiasis: A stone lucencies analysis
    Bramono, Ikhlas Arief
    Birowo, Ponco
    Rasyid, Nur
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 109 - 109
  • [36] Absorptive and transformative capacities in nanotechnology innovation systems
    Pandza, Krsto
    Holt, Robin
    JOURNAL OF ENGINEERING AND TECHNOLOGY MANAGEMENT, 2007, 24 (04) : 347 - 365
  • [37] Nanotechnology in inflammation: cutting-edge advances in and theranostics
    Liu, Yuting
    Lin, Ziqi
    Wang, Yuting
    Chen, Liuhui
    Wang, Yuequan
    Luo, Cong
    THERANOSTICS, 2024, 14 (06): : 2490 - 2525
  • [38] Combining Antimicrobial Peptides with Nanotechnology: An Emerging Field in Theranostics
    Mohid, Sk Abdul
    Bhunia, Anirban
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2020, 21 (04) : 413 - 428
  • [39] From Oncogenesis to Theranostics: The Transformative Role of PSMA in Prostate Cancer
    Hameed, Muhammad Y.
    Gul, Maryam
    Chaudhry, Abbas
    Muzaffar, Huma
    Sheikh, Mubashir
    Chee, Winson
    Ayyash, Sondos
    Ayyash, Jenna
    Al-Hindi, Mohannad
    Shahare, Humam
    Chaudhry, Ammar
    CANCERS, 2024, 16 (17)
  • [40] Metaphylaxis of kidney stone disease as a strategy to reduce the burden of urolithiasis at the Brazilian private health care sector
    Junior Augusto Cesar, Soares dos Santos
    Augusto, Meneses Jose
    12TH INTERNATIONAL SYMPOSIUM ON UROLITHIASIS, 2012, : 57 - 60